吉西他滨联合顺铂与紫杉醇联合顺铂一线治疗晚期三阴性乳腺癌的效果比较

2018-02-22 14:28:04莫淑芬钟海鸣许靖靖陈景胜
中国当代医药 2018年35期
关键词:顺铂紫杉醇效果

莫淑芬 钟海鸣 许靖靖 陈景胜

[摘要]目的 比较吉西他滨联合顺铂(GP)与紫杉醇联合顺铂(TP)一线治疗晚期三阴性乳腺癌(TNBC)的效果。方法 选取2015年7月~2017年7月我院收治的44例晚期TNBC患者作为研究对象,按照随机数字表法将其分为GP组和TP组,每组各22例。GP组给予吉西他滨联合顺铂方案进行化疗,TP组采用紫杉醇联合顺铂方案进行化疗。两组治疗均以21 d为1个疗程,共治疗6个疗程,每治疗2个疗程后评价比较两组的临床效果和毒副反应。结果 两组治疗2个疗程的总有效率比较,差异无统计学意义(P>0.05)。TP组治疗4、6个疗程时的总有效率高于GP组,差异有统计学意义(P<0.05)。两组治疗的毒副反应方面比较,差异无统计学意义(P>0.05)。结论 吉西他滨联合顺铂与紫杉醇联合顺铂一线治疗晚期TNBC的毒副作用相当,但紫杉醇联合顺铂治疗的临床效果更佳,适宜作为晚期TNBC的一线化疗方案。

[关键词]三阴性乳腺癌;顺铂;吉西他滨;紫杉醇;效果

[中图分类号] R737.9 [文献标识码] A [文章编号] 1674-4721(2018)12(b)-0044-04

[Abstract] Objective To compare the efficacy of Gemcitabine combined with Cisplatin (GP) and Paclitaxel combined with Cisplatin (TP) in the treatment of advanced triple-negative breast cancer(TNBC). Methods A total of 44 patients with advanced TNBC admitted to our hospital from July 2015 to July 2017 were selected as study subjects. According to random digital table method, they were randomly divided into the GP group and the TP group, 22 patients in each group. The GP group was treated with Gemcitabine combined with Cisplatin regimen, and the TP group was treated with Paclitaxel combined with Cisplatin regimen. Two groups were treated with 21 days as a course of treatment, a total of 6 courses of treatment. The clinical efficacy and side effects were compared after two courses of treatment between the two groups. Results There was no significant difference in the total effective rate between the two groups after 2 courses of treatment (P>0.05). In the course of 4, 6 treatment, the total effective rate in the TP group were higher than that in the GP group, and the differences were statistically significant (P<0.05). There was no significant difference in side effects between the two groups (P>0.05). Conclusion Gemcitabine combined with Cisplatin and Paclitaxel combined with Cisplatin have the same toxicity in the treatment of advanced TNBC, but Paclitaxel combined with Cisplatin has better clinical efficacy and is suitable for first-line chemotherapy of advanced TNBC.

[Key words] Triple negative breast cancer; Cisplatin; Gemcitabine; Paclitaxel; Curative effect

乳腺癌是女性最常見的恶性肿瘤之一,其发病率呈不断上升的趋势[1]。乳腺癌的复发性较强,具有较高病死率,严重危害女性生命健康。其中三阴性乳腺癌(TNBC)是乳腺癌的一种特殊亚型,特指ER、PR、HER-2表达均为阴性的乳腺癌患者。数据统计发现TNBC在所有浸润性乳腺癌的占比为16%~20%[2-3]。TNBC亚型有高度的侵袭性和复杂的生物学行为,相较于其他亚型的乳腺癌具有恶化程度高、复发转移率高及生存率低的特点[4]。TNBC对靶向治疗和内分泌治疗均不敏感,因此化疗是目前治疗晚期TNBC的主要手段[5]。不过目前关于其标准的一线化疗方案尚没有明确标准。吉……

登录APP查看全文

猜你喜欢
顺铂紫杉醇效果
按摩效果确有理论依据
迅速制造慢门虚化效果
抓住“瞬间性”效果
中华诗词(2018年11期)2018-03-26 06:41:34
紫杉醇脂质体与紫杉醇不同途径灌注治疗兔舌癌的疗效研究
脂质体紫杉醇周疗方案与普通紫杉醇治疗乳腺癌的疗效及不良反应比较
中外医疗(2016年15期)2016-12-01 04:25:50
细胞自噬与人卵巢癌细胞对顺铂耐药的关系
紫杉醇联合顺铂冶疗食管癌的效果观察
奈达铂与顺铂同步放化疗治疗中晚期宫颈癌的疗效差异
吉西他滨联合顺铂治疗晚期三阴乳腺癌的疗效观察
模拟百种唇妆效果
Coco薇(2016年8期)2016-10-09 02:11:50